Literature DB >> 23935066

Epigenetic regulation of ADME-related genes: focus on drug metabolism and transport.

Xiao-bo Zhong1, J Steven Leeder.   

Abstract

Epigenetic regulation of gene expression refers to heritable factors that are functionally relevant genomic modifications but that do not involve changes in DNA sequence. Examples of such modifications include DNA methylation, histone modifications, noncoding RNAs, and chromatin architecture. Epigenetic modifications are crucial for packaging and interpreting the genome, and they have fundamental functions in regulating gene expression and activity under the influence of physiologic and environmental factors. Recently, epigenetics has become one of the fastest-growing areas of science and has now become a central issue in biologic studies of development and disease pathogenesis. The interest in epigenetics is also true for studies of drug metabolism and transport. In this issue of Drug Metabolism and Disposition, a series of articles is presented to demonstrate the role of epigenetic factors in regulating the expression of genes involved in drug absorption, distribution, metabolism, and excretion in organ development, tissue-specific gene expression, sexual dimorphism, and in the adaptive response to xenobiotic exposure, both therapeutic and toxic. The articles also demonstrate that, in addition to genetic polymorphisms, epigenetics may also contribute to wide interindividual variations in drug metabolism and transport. Identification of functionally relevant epigenetic biomarkers in human specimens has the potential to improve prediction of drug responses based on patient's epigenetic profiles.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23935066      PMCID: PMC3920173          DOI: 10.1124/dmd.113.053942

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  39 in total

1.  DNA methylation profiles of CpG islands for cellular differentiation and development in mammals.

Authors:  K Shiota
Journal:  Cytogenet Genome Res       Date:  2004       Impact factor: 1.636

Review 2.  A decade of exploring the cancer epigenome - biological and translational implications.

Authors:  Stephen B Baylin; Peter A Jones
Journal:  Nat Rev Cancer       Date:  2011-09-23       Impact factor: 60.716

Review 3.  Epigenetic-dependent regulation of drug transport and metabolism: an update.

Authors:  Marina Kacevska; Maxim Ivanov; Magnus Ingelman-Sundberg
Journal:  Pharmacogenomics       Date:  2012-09       Impact factor: 2.533

4.  Insights into insulin-mediated regulation of CYP2E1: miR-132/-212 targeting of CYP2E1 and role of phosphatidylinositol 3-kinase, Akt (protein kinase B), mammalian target of rapamycin signaling in regulating miR-132/-212 and miR-122/-181a expression in primary cultured rat hepatocytes.

Authors:  Upasana Shukla; Nithin Tumma; Theresa Gratsch; Alan Dombkowski; Raymond F Novak
Journal:  Drug Metab Dispos       Date:  2013-08-06       Impact factor: 3.922

5.  Genome-wide analysis of epigenetic signatures for kidney-specific transporters.

Authors:  Ryota Kikuchi; Shintaro Yagi; Hiroyuki Kusuhara; Satoki Imai; Yuichi Sugiyama; Kunio Shiota
Journal:  Kidney Int       Date:  2010-06-16       Impact factor: 10.612

6.  DNA methylation dynamics in the hepatic CYP3A4 gene promoter.

Authors:  Marina Kacevska; Maxim Ivanov; Annika Wyss; Silva Kasela; Lili Milani; Anders Rane; Magnus Ingelman-Sundberg
Journal:  Biochimie       Date:  2012-07-31       Impact factor: 4.079

Review 7.  Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation.

Authors:  Ulrich M Zanger; Matthias Schwab
Journal:  Pharmacol Ther       Date:  2013-01-16       Impact factor: 12.310

Review 8.  Sex differences in the expression of hepatic drug metabolizing enzymes.

Authors:  David J Waxman; Minita G Holloway
Journal:  Mol Pharmacol       Date:  2009-05-29       Impact factor: 4.436

9.  The rat P450IIE1 gene: complete intron and exon sequence, chromosome mapping, and correlation of developmental expression with specific 5' cytosine demethylation.

Authors:  M Umeno; B J Song; C Kozak; H V Gelboin; F J Gonzalez
Journal:  J Biol Chem       Date:  1988-04-05       Impact factor: 5.157

10.  Regulation of microRNA expression by rifampin in human hepatocytes.

Authors:  Anuradha Ramamoorthy; Yunlong Liu; Santosh Philips; Zeruesenay Desta; Hai Lin; Chirayu Goswami; Andrea Gaedigk; Lang Li; David A Flockhart; Todd C Skaar
Journal:  Drug Metab Dispos       Date:  2013-08-09       Impact factor: 3.922

View more
  12 in total

Review 1.  MicroRNA Pharmacoepigenetics: Posttranscriptional Regulation Mechanisms behind Variable Drug Disposition and Strategy to Develop More Effective Therapy.

Authors:  Ai-Ming Yu; Ye Tian; Mei-Juan Tu; Pui Yan Ho; Joseph L Jilek
Journal:  Drug Metab Dispos       Date:  2015-11-13       Impact factor: 3.922

2.  MicroRNA hsa-miR-29a-3p modulates CYP2C19 in human liver cells.

Authors:  Dianke Yu; Bridgett Green; William H Tolleson; Yaqiong Jin; Nan Mei; Yongli Guo; Helen Deng; Igor Pogribny; Baitang Ning
Journal:  Biochem Pharmacol       Date:  2015-08-19       Impact factor: 5.858

3.  A systematic review and meta-analysis of randomized trials on the role of targeted therapy in the management of advanced gastric cancer: Evidence does not translate?

Authors:  Domenico Ciliberto; Nicoletta Staropoli; Francesca Caglioti; Simona Gualtieri; Lucia Fiorillo; Silvia Chiellino; Antonina Maria De Angelis; Francesco Mendicino; Cirino Botta; Michele Caraglia; Pierfrancesco Tassone; Pierosandro Tagliaferri
Journal:  Cancer Biol Ther       Date:  2015-06-10       Impact factor: 4.742

4.  The Promises of Quantitative Proteomics in Precision Medicine.

Authors:  Bhagwat Prasad; Marc Vrana; Aanchal Mehrotra; Katherine Johnson; Deepak Kumar Bhatt
Journal:  J Pharm Sci       Date:  2016-12-08       Impact factor: 3.534

Review 5.  microRNAs as pharmacogenomic biomarkers for drug efficacy and drug safety assessment.

Authors:  Igor Koturbash; William H Tolleson; Lei Guo; Dianke Yu; Si Chen; Huixiao Hong; William Mattes; Baitang Ning
Journal:  Biomark Med       Date:  2015-10-26       Impact factor: 2.851

6.  Coordinated Regulation of UGT2B15 Expression by Long Noncoding RNA LINC00574 and hsa-miR-129-5p in HepaRG Cells.

Authors:  Dianke Yu; Jing Chen; Si Chen; Lin Xu; Leihong Wu; Dongying Li; Jiao Luo; Yuan Jin; Yanjie Zhao; Bridgett Knox; William H Tolleson; Xubing Wang; Lei Guo; Weida Tong; Baitang Ning
Journal:  Drug Metab Dispos       Date:  2020-02-21       Impact factor: 3.922

7.  Age-dependent Protein Abundance of Cytosolic Alcohol and Aldehyde Dehydrogenases in Human Liver.

Authors:  Deepak Kumar Bhatt; Andrea Gaedigk; Robin E Pearce; J Steven Leeder; Bhagwat Prasad
Journal:  Drug Metab Dispos       Date:  2017-06-12       Impact factor: 3.922

8.  Epigenome-Microbiome crosstalk: A potential new paradigm influencing neonatal susceptibility to disease.

Authors:  Rene Cortese; Lei Lu; Yueyue Yu; Douglas Ruden; Erika C Claud
Journal:  Epigenetics       Date:  2016-02-24       Impact factor: 4.861

9.  From inflammaging to healthy aging by dietary lifestyle choices: is epigenetics the key to personalized nutrition?

Authors:  Katarzyna Szarc vel Szic; Ken Declerck; Melita Vidaković; Wim Vanden Berghe
Journal:  Clin Epigenetics       Date:  2015-03-25       Impact factor: 6.551

10.  Differences in the Epigenetic Regulation of Cytochrome P450 Genes between Human Embryonic Stem Cell-Derived Hepatocytes and Primary Hepatocytes.

Authors:  Han-Jin Park; Young-Jun Choi; Ji Woo Kim; Hang-Suk Chun; Ilkyun Im; Seokjoo Yoon; Yong-Mahn Han; Chang-Woo Song; Hyemin Kim
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.